Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer

Lancet Oncol. 2023 Sep;24(9):946-947. doi: 10.1016/S1470-2045(23)00394-7.

Author

Dean A Fennell¹

Affiliation

¹ NIHR Biomedical Research Centre Leicester and Cancer Research UK Experimental Cancer Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester LE2 7LX, UK. Electronic address: df132@leicester.ac.uk.

PMID: 37657465
DOI: 10.1016/S1470-2045(23)00394-7

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / therapy
Humans
Immunotherapy / adverse effects
Lung Neoplasms* / therapy